Weekly Low-Dose Doxorubicin with or Without High-Dose Medroxyprogesterone Acetate as Secondary Treatment in Metastatic Breast Cancer—A Randomized Trial

Authors

  • I. Elomaa Department of Radiotherapy and Oncology, University of Helsinki, Helsinki, Finland
  • C. Blomqvist Department of Radiotherapy and Oncology, University of Helsinki, Helsinki, Finland
  • P. Rissanen Department of Radiotherapy and Oncology, University of Helsinki, Helsinki, Finland
  • M. Mäntylä Department of Radiotherapy and Oncology, University of Helsinki, Helsinki, Finland

DOI:

https://doi.org/10.3109/02841868809093543

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

1988-01-01

How to Cite

Elomaa, I., Blomqvist, C., Rissanen, P., & Mäntylä, M. (1988). Weekly Low-Dose Doxorubicin with or Without High-Dose Medroxyprogesterone Acetate as Secondary Treatment in Metastatic Breast Cancer—A Randomized Trial. Acta Oncologica, 27(3), 297–299. https://doi.org/10.3109/02841868809093543

Issue

Vol. 27 No. 3 (1988): Acta Oncologica

Section

Articles